Abstract:OBJECTIVE:To summarize the experience in diagnosis and surgical treatment of hepatic cholangiocarcinoma.METHODS:Clinical features, diagnosis, surgical treatment and prognosis of 52 patients with hepatic cholangiocarcinoma treated at our hospital from 1993 to 2001 were retrospectively reviewed.RESULTS:The patients with hepatic cholangiocarcinoma accounted for 4.1% (52/1261) of the total patients with primary liver carcinoma encountered at this hospital. The ratio of male to female was 1.36:1 in this group. Some patients were complicated by hepatitis B (32.7%), hepatolith (34.6%), liver abscess (13.5%), cirrhosis (53.8%), and serum positivity for alpha-fetaprotein (21.2%). No typical clinical manifestations were present in all patients. The diagnostic rates of ultrasound examination and CT were 80.8% and 94.2%, respectively. The resection rate of hepatic cholangiocarcinoma was 48.1%; and the 1-, 3-, 5-year survival rates were 48.1% (25/52), 30.8% (16/52), and 19.2% (10/52) respectively in this group. In resectable cases, the 1-, 3-, 5-year survival rats were 80.8% (20/25), 48.0% (12/25), 28.0% (7/25) respectively. Seven patients without cirrhosis who had received radical resection and intra-arterial chemotherapy survived for more than 5 years. In unresectable 27 cases, only 5 survived over one year even if selective hepatic arterial embolism and perfusion chemotherapy were employed.CONCLUSIONS:No specific serum marker is found for hepatic cholangiocarcinoma. CT diagnosis is superior to ultrasonography. When a patient has already diagnosed as having hepatolith or liver abscess before operation and occupying lesion is seen intraoperatively, rapid pathological examination should be done for a fair judgement of the nature of the mass and a decision-making of operative protocol. The patient can survive well after curative resection. No matter whether hepatic cholangiocarcinoma is resectable of not, both selective hepatic arterial embolism and perfusion chemotherapy are valuable.

Diagnosis and Treatment of Primary Liver Cancer with Cancer Thrombus of the Bile Duct

Hepatocellular Carcinoma with Bile Duct Thrombi: Analysis of Surgical Treatment.

Surgical Treatment on Hepatocellular Carcinoma(HCC) with Bile Duct Tumor Thrombi

Imaging Diagnosis and Interventional Treatment for the Primary Hepatocellular Carcinoma with Biliary Obstruction

Diagnosis and Surgical Treatments of Hepatocellular Carcinoma with Tumor Thrombosis in Bile Duct: Experience of 34 Patients

Surgical Treatment for Giant Primary Liver Cancer:A Report of 146 Cases

Diagnosis Experience of Primary Liver Carcinoma Complicated with Bile Duct Embolus

Caution for diagnosis and surgical treatment of recurrent cholangitis: lessons from 5 cases of bile duct tumor thrombus without a detectable intrahepatic tumor.

Diagnosis and Treatment of Primary Hepatocellular Cancer with Bile Duct Tumor Thrombi

Caution for Diagnosis and Surgical Treatment of Recurrent Cholangitis

Treatment of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus

Surgical Treatment of Hepatocellular Carcinoma with Bile Duct Tumor Thrombi

Surgical Intervention for Hepatocellular Carcinoma with Bile Buct Thrombi

Surgical Treatment for Primary Liver Cancer with Portal Vein Tumor Thrombus(13 Cases Report)

Diagnosis and Treatment of Hepatic Cholangiocarcinoma: Report of 52 Cases.

DIAGNOSIS AND TREATMENT OF PRIMARY GALLBLADDER CARCINOMA WITH BILE DUCT OBSTRUCTIN

Clinicopathological features,diagnosis and treatment of hepatolithiasis complicated with cholangiocarcinoma

Hepatocellular carcinoma with tumor thrombus in bile duct: A proposal of new classification according to resectability of primary lesion

The comprehensive therapy for primary liver cancer

Hepatocellular carcinoma with bile duct tumor thrombus: a clinicopathological analysis of factors predictive of recurrence and outcome after surgery.

Surgical management for hepatocellular carcinoma with concurrent portal vein tumour thrombus and bile duct tumour thrombus: a case report